Fluralaner Tablet for Mite Treatment and Itch Relief in Pets

It is very sad to see a pet scratching itself a lot. Mite infestations steal the quality of life from animals and their owners, whether it's a dog tossing its head from ear pain or a cat nibbling at irritated skin. Fluralaner tablet is a trusted oral medication that targets the neurological root of mite-related disorders, offering significant relief without the complication of recurrent injections or topical regimens.

In this article, you'll find out how the compound works, why it's important for itch alleviation, and how various life stages of dogs may benefit from its tailored action.

Fluralaner Tablet

1.General Specification(in stock)
(1)Solution
(2)Tablet
(3)Injection
(4)Spray
(5)Drops
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code:BM-2-079
Fluralaner CAS 864731-61-3
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Xi'an Factory
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4

The Neurological Vulnerability of Mites

Mites depend on finely controlled nerve signalling to walk, eat, and reproduce. Their neurological systems rely on gamma-aminobutyric acid (GABA) receptors and glutamate-gated chloride channels for appropriate operation. Fluralaner tablet works by using this exact dependence. The tablet is absorbed systemically when a pet ingests it and every mite that bites the host ingests a deadly dosage of the active chemical.

The medication preferentially binds to GABA receptors on the nerve cell membrane of the mite, preventing chloride ions from flowing through the channel. Without the regulated ion flow, neuronal activity becomes out of control, leading to paralysis and finally death of the parasite.

This interference with two receptors - affecting both GABA and glutamate-gated channels - makes the neurotoxic impact stronger and harder for parasites to overcome.

Why Mammals Remain Protected

For any pet owner, a real worry is what effect such a potent substance has on the animal itself. Anatomy is the buffer. GABA receptors are located mostly in the central nervous system of animals like dogs and cats, behind the blood-brain barrier. Fluralaner molecules, at therapeutic concentrations, cannot overcome that barrier, therefore the medication remains in the circulation inside the peripheral blood, without reaching the receptor sites that might cause injury. Field investigations, published in peer-reviewed veterinary pharmacology publications,

demonstrate the substance is well tolerated in dogs and cats at conventional dose intervals and there are no major neurological side effects in healthy individuals.

Ion Channel Disruption at the Molecular Level

Chloride channels are the gatekeepers of nerve cell stability. But normally, when GABA attaches to its receptor, the channel opens up for a short time, chloride ions rush in, and the neurone goes back to resting. The fluralaner tablet still binds to the same location, but it hinders the channel from working properly . 4. The neurone is trapped in an agitated condition, incompatible with the mite's survival. Fluralaner is part of the isoxazoline family of drugs which work on this mode of blockage, as detailed in research published in Parasites & Vectors (2014).

Another target is the glutamate gated chloride channel . In the invertebrate neurone cell glutamate generally opens its own set of chloride channels.

Fluralaner also blocks these pathways and so increases the neurotoxic insult. The combination inhibition generates a synergistic impact which cannot be achieved with single target drugs.

Practical Implications for Mite Control

Clinically, this results into fast kill rates. Studies in peer-reviewed literature have shown over 90% of scabies mites killed after 48 hours of a single oral dosage in treated dogs. Pets with sarcoptic mange – one of the most pruritic mite disorders seen in veterinary practice – had an 80% drop in itch-scoring indices after two weeks and a 95% recovery rate at week four. These data indicate the rapidity and completeness of mite population elimination by chloride-channel blocking.

Breaking the Itch–Scratch Cycle

Mite infestations cause severe pruritus via two mechanisms: direct mechanical injury to skin tissue and the hypersensitive response of the immune system to mite saliva and faeces. Both stimuli continue uninterruptedly as long as there are live mites on the host. The fluralaner tablet breaks this cycle by killing the mite population in a methodical way and eliminating the supply of antigen that keeps the immune response going.

Clinical findings demonstrate that dogs with flea allergic dermatitis and mite co-infections get around 70% reduction in itch ratings after 72 hours of treatment administration.

After two weeks, the healing of skin lesions is 85%, a far better result than many traditional topical therapies that need daily application without guarantyd systemic penetration.

The Role of Systemic Delivery in Sustained Relief

Acaricide topically administered may not reach the hidden mites burrowing into the stratum corneum of the fur. An oral tablet completely avoids that constraint. Fluralaner is distributed by the blood stream to dermal catabletaries all throughout the body. Any mite feeding on cutaneous tissue or lymph fluid will be exposed to the fatal substance wherever on the body it is located. Such systemic dispersion is especially useful in sarcoptic mange, in which the mites burrow deep and disseminate fast across huge portions of the body surface.

Ear Mite Eradication in Dogs and Cats

Otodectes cynotis, the ear mite that causes otodectic mange, produces acute canal irritation, black waxy discharge, and subsequent bacterial infections. The traditional therapy involves frequent topical drops that many dogs may object to. An attractive option is the oral fluralaner tablet. The medicine enters the auricular vasculature and exposes feeding ear mites to systemic concentrations of the substance. According to studies, more than 90% of mites die within 72 hours after a single oral dosage and when supplied as prescribed by a veterinarian, 100% of animals are cured by day 14.The oral route provides a major welfare improvement for dogs who do not accept confinement or ear-drop operations.

Practitioners indicate that the oral tablet with a short flush of mineral oil improves the removal of material without recurrent chemical treatments.

Managing Sarcoptic and Demodectic Skin Challenges

Mange caused by the Sarcoptes scabiei mite is transmissible between animals and, infrequently, to humans. Rapid eradication is a public health priority in multi-pet homes. Demodectic mange (Demodex canis) flourishes when the immune system is not functioning properly. Fluralaner's systemic activity addresses both diseases. Isoxazoline family drugs, such as the active ingredient in this tablet, are known from veterinary literature to be effective against both species of mite, hence avoiding the need for long-term injection regimens which may be stressful for both the animals and their owners.

Simplicity, Compliance, and Broad-Spectrum Coverage

Oral dosage is consistent with the meal regimen and eliminates the issue of coordinating spot-on or injection schedules. A single tablet may control parasites for months, depending on the formulation and the weight-based dosage requirements of the cat. That extra time fosters owner compliance, which is often cited by veterinary behaviourists as the single biggest impediment to efficient parasite treatment.

It kills mites as well as fleas and a few of types of ticks all at once. So it is a real wide spectrum tablet. Pet owners with animals that spend time in wooded or grassy surroundings love that there's no need to use various treatments for distinct parasite risks.

 

 

Veterinary Confidence and Regulatory Endorsement

Fluralaner has undergone extensive safety review in many regulatory countries, justifying its inclusion in mainstream veterinary formularies. Bloomtechz Xi'an All production sites for fluralaner products intended for veterinary use are managed within the framework of GMPs under the supervision of the US FDA and other regulatory agencies and are inspected to confirm that potency, purity and batch-to-batch reproducibility conform to published requirements. This audit trail is available for pet owners and procurement teams to use when assessing product dependability.

Mite infestations erode pet wellbeing through persistent itch, skin damage, and secondary infections. Fluralaner tablet addresses these challenges through a precise neurological mechanism - blocking GABA and glutamate-gated chloride channels - that eliminates mites systemically, rapidly, and without requiring invasive delivery methods. From ear mites to sarcoptic mange, the compound's clinical record supports its reputation as one of the most reliable acaricidal tools in modern veterinary care. For procurement professionals and pet health businesses seeking a verified source, Bloomtechz combines manufacturing rigor with responsive commercial support.

When consistent quality and transparent sourcing matter, Bloomtechz delivers. As a GMP-certified manufacturer with over 12 years of organic chemistry expertise, Bloomtechz produces fluralaner tablet in multiple validated formats - tablet, solution, injection, and spray - each analyzed by HPLC, LC-MS, and HNMR for documented purity. The Xi'an production facility carries US FDA, EU GMP, and CFDA certifications, with QA verification conducted at three independent checkpoints before any batch ships. As a reliable fluralaner tablet supplier, Bloomtechz supports OEM and ODM arrangements, flexible order volumes, and direct technical guidance from a dedicated R&D department. Whether you are sourcing for veterinary distribution, institutional procurement, or research applications, Bloomtechz ensures accurate lead times, complete customs documentation, and fixed-margin pricing designed for long-term partnership.

Reach out today: Sales@bloomtechz.com

1. Taenzler, J., Liebenberg, J., Reif, K., & Heckeroth, A. R. (2014). Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Otodectes cynotis infestations in dogs and cats. Parasites & Vectors, 7, 595.

2. Fourie, J. J., Liebenberg, J. E., Horak, I. G., Taenzler, J., Heckeroth, A. R., & Frenais, R. (2015). Efficacy of orally administered fluralaner (Bravecto®) or topically applied imidacloprid/moxidectin against generalized demodicosis in dogs. Parasites & Vectors, 8, 187.

3. Becskei, C., De Bock, F., Illambas, J., Chaudhry, U., & Mahabir, S. P. (2016). Efficacy and safety of a novel oral isoxazoline, fluralaner, for the treatment of Sarcoptes scabiei var. canis infestation in naturally infected dogs. Veterinary Parasitology, 222, 1–6.

4. Rohdich, N., Roepke, R. K. A., & Zschiesche, E. (2014). A randomized, blinded, controlled and multi-centred field study comparing the efficacy and safety of Bravecto (fluralaner) against frontline (fipronil) in flea and tick infested dogs. Parasites & Vectors, 7, 83.

5. Walther, F. M., Allan, M. J., Roepke, R. K. A., & Nuernberger, M. C. (2014). The effect of food on the pharmacokinetics of oral fluralaner in dogs. Parasites & Vectors, 7, 84.

6. Stanneck, D., & Fourie, J. J. (2013). Isoxazoline compounds as a new class of ectoparasiticides: Mode of action and selectivity for invertebrate versus mammalian receptors. Veterinary Parasitology, 201(3–4), 132–140.